Analyst consensus rating
Wave Life Sciences Analyst Rating: Strong Buy
WVE is rated Strong Buy by 16 analysts with a $19.06 target. As of 2026-09-01.
Direct answer
Wave Life Sciences's consensus rating is Strong Buy.
16 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $19.06.
Forecast evidence checked September 1, 2026.
Get free Wave Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.90
- Average price target
- $19.06
- High price target
- $42.00
- Low price target
- $12.00
- Low target gap
- +144.9%
- Target upside
- +289%
- High target gap
- +757.1%
- Target range width
- 612.2%
- Consensus rating
- Strong Buy
- Analysts
- 16
- Evidence date
- September 1, 2026
- Valid through
- September 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Wave Life Sciences?
Wave Life Sciences has a verified Strong Buy consensus. The same dataset has an average price target of $19.06.
How far are Wave Life Sciences's low and high targets from the recorded price?
The low target implies +144.9%, while the high target implies +757.1%.
How many analysts are included in Wave Life Sciences's consensus?
The verified consensus includes 16 analysts.
How is Wave Life Sciences's target upside or downside calculated?
The average target of $19.06 is divided by the recorded price of $4.90, then one is subtracted to produce +289%. This does not guarantee a future return.
When was Wave Life Sciences's analyst forecast verified?
The data was verified on 2026-09-01. The dataset is valid through 2026-09-08.